Deep Multi-Omic Profiling Reveals Molecular Signatures that Underpin Preschool Wheeze and Asthma.

asthma disease trajectory gene expression lipidomics metabolomics metagenomics multi-omics wheeze

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
28 Aug 2024
Historique:
received: 19 06 2024
revised: 16 08 2024
accepted: 23 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: aheadofprint

Résumé

Wheezing in childhood is prevalent, with over half of all children experiencing at least one episode by age six. The pathophysiology of wheeze, especially why some children develop asthma while others do not, remains unclear. This study addresses the knowledge gap by investigating the transition from preschool wheeze to asthma using multi-omic profiling. Unsupervised, group-agnostic integrative multi-omic factor analysis was performed using host/bacterial (meta-)transcriptomic and bacterial shotgun metagenomic datasets from bronchial brush samples paired with metabolomic/lipidomic data from bronchoalveolar lavage samples acquired from children 1-17 years old. Two multi-omic factors were identified: one characterising preschool-aged recurrent wheeze and another capturing an inferred trajectory from health to wheeze and school-aged asthma. Recurrent wheeze was driven by Type 1-immune signatures, coupled with upregulation of immune-related and neutrophil-associated lipids and metabolites. Comparatively, progression towards asthma from ages 1-18 was dominated by changes related to airway epithelial cell gene expression, Type 2-immune responses, and constituents of the airway microbiome, such as increased Haemophilus influenzae. These factors highlighted distinctions between an inflammation-related phenotype in preschool wheeze, and the predominance of airway epithelial-related changes linked with the inferred trajectory toward asthma. These findings provide insights into the differential mechanisms driving the progression from wheeze to asthma and may inform targeted therapeutic strategies.

Sections du résumé

BACKGROUND BACKGROUND
Wheezing in childhood is prevalent, with over half of all children experiencing at least one episode by age six. The pathophysiology of wheeze, especially why some children develop asthma while others do not, remains unclear.
OBJECTIVE OBJECTIVE
This study addresses the knowledge gap by investigating the transition from preschool wheeze to asthma using multi-omic profiling.
METHODS METHODS
Unsupervised, group-agnostic integrative multi-omic factor analysis was performed using host/bacterial (meta-)transcriptomic and bacterial shotgun metagenomic datasets from bronchial brush samples paired with metabolomic/lipidomic data from bronchoalveolar lavage samples acquired from children 1-17 years old.
RESULTS RESULTS
Two multi-omic factors were identified: one characterising preschool-aged recurrent wheeze and another capturing an inferred trajectory from health to wheeze and school-aged asthma. Recurrent wheeze was driven by Type 1-immune signatures, coupled with upregulation of immune-related and neutrophil-associated lipids and metabolites. Comparatively, progression towards asthma from ages 1-18 was dominated by changes related to airway epithelial cell gene expression, Type 2-immune responses, and constituents of the airway microbiome, such as increased Haemophilus influenzae.
CONCLUSION CONCLUSIONS
These factors highlighted distinctions between an inflammation-related phenotype in preschool wheeze, and the predominance of airway epithelial-related changes linked with the inferred trajectory toward asthma. These findings provide insights into the differential mechanisms driving the progression from wheeze to asthma and may inform targeted therapeutic strategies.

Identifiants

pubmed: 39214237
pii: S0091-6749(24)00869-8
doi: 10.1016/j.jaci.2024.08.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Matthew Macowan (M)

Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia.

Céline Pattaroni (C)

Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia. Electronic address: celine.pattaroni@monash.edu.

Katie Bonner (K)

Imperial Centre for Paediatrics and Child Health, and National Heart and Lung Institute, Imperial College London, United Kingdom.

Roxanne Chatzis (R)

Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia.

Carmel Daunt (C)

Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia.

Mindy Gore (M)

Imperial Centre for Paediatrics and Child Health, and National Heart and Lung Institute, Imperial College London, United Kingdom.

Adnan Custovic (A)

Imperial Centre for Paediatrics and Child Health, and National Heart and Lung Institute, Imperial College London, United Kingdom; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.

Michael D Shields (MD)

Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.

Ultan F Power (UF)

Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.

Jonathan Grigg (J)

Centre for Child Health, Blizard Institute, Queen Mary University of London, United Kingdom.

Graham Roberts (G)

Human Development in Health School, University of Southampton Faculty of Medicine, Southampton, United Kingdom; NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; David Hide Asthma and Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight, United Kingdom.

Peter Ghazal (P)

School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.

Jürgen Schwarze (J)

Centre for Inflammation Research, Child Life and Health, The University of Edinburgh, Edinburgh, United Kingdom.

Steve Turner (S)

Child Health, University of Aberdeen, Aberdeen, United Kingdom; NHS Grampian, Aberdeen, United Kingdom.

Andrew Bush (A)

Imperial Centre for Paediatrics and Child Health, and National Heart and Lung Institute, Imperial College London, United Kingdom.

Sejal Saglani (S)

Royal Brompton Hospital, London, United Kingdom; National Heart & Lung Institute, Imperial College London, United Kingdom.

Clare M Lloyd (CM)

National Heart & Lung Institute, Imperial College London, United Kingdom.

Benjamin J Marsland (BJ)

Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Australia.

Classifications MeSH